- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg med PD-1 inhibitor
I alt 6246 resultater
-
Sun Yat-sen UniversityRekrutteringPD-1 inhibitor | G-CSFKina
-
Sun Yat-sen UniversityRekrutteringPD-1 inhibitor | Granulocytkoloni-stimulerende faktorKina
-
Sichuan UniversityRekrutteringNSCLC | PD-1 inhibitor | Leptomeningeal metastase | Lavdosis strålebehandlingKina
-
Guohui LiRekrutteringPD-1 | Immunrelaterede bivirkningerKina
-
RenJi HospitalRekrutteringUrothelial carcinom blære | PD-1 inhibitorKina
-
Baodong QinUkendtKemoterapi effekt | Immunterapi | Tumormutationsbyrde | PD-1/L1-hæmmerKina
-
First People's Hospital of HangzhouHangzhou Cancer HospitalRekrutteringStereotaktisk kropsstrålingsterapi; PD-1 inhibitor; hypertermi; NSCLCKina
-
Merck Sharp & Dohme LLCRekrutteringIkke-småcellet lungekræft | Faste tumorer | Programmeret celledød-1 (PD1, PD-1) | Programmeret celledød 1 Ligand 1 (PDL1, PD-L1) | Programmeret celledød 1 ligand 2 (PDL2, PD-L2)Japan
-
Peking Union Medical College HospitalRekrutteringHepatocellulært karcinom | PD-1 inhibitor | RegorafenibKina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital of Jinan University; Shenzhen University General...RekrutteringKarcinom | Neoplasmer i fordøjelsessystemet | Intrahepatisk cholangiocarcinom | Førstelinjes behandling | PD-1 inhibitorKina
-
Sun Yat-sen UniversityRekrutteringHepatocellulært karcinom | PD-1 inhibitor | Lenvatinib | Hepatisk arteriel infusion KemoterapiKina
-
Sichuan UniversityRekrutteringNSCLC | PD-1 inhibitor | Stereotaktisk kropsstrålebehandling | Lavdosis strålebehandlingKina
-
Ningbo Cancer HospitalUkendtAvancerede maligniteter | PD-1 antistof | CAR-T cellerKina
-
Shanghai International Medical CenterUkendtAvanceret solid tumor | PD-1 antistof | CAR-T cellerKina
-
University Hospital, MontpellierAfsluttetPatienter, der modtager anti-PD-1 eller Anti-PD-L1 immunterapierFrankrig
-
Peking UniversityIkke rekrutterer endnuGastroøsofageal Junction Cancer | Kemoradioterapi | PD-1
-
Agenus Inc.AfsluttetAvancerede solide kræftformer | Advanced Solid Cancers Refractory to PD-1Forenede Stater
-
Fujian Cancer HospitalIkke rekrutterer endnuLunge Adenocarcinom | PD-1 inhibitor | Stadie IV Ikke-småcellet lungekræft | VEGF
-
Beijing Friendship HospitalIkke rekrutterer endnu
-
Nanfang Hospital of Southern Medical UniversityRekrutteringEsophageal pladecellekarcinom | PD-1 inhibitorKina
-
Tang-Du HospitalRekrutteringKemoterapi | Esophageal pladecellekarcinom | PD-1 inhibitor | NeoadjuventKina
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityRekrutteringNasopharyngealt karcinom | Capecitabin | Strålebehandling | PD-1 inhibitorKina
-
Indiana Hemophilia &Thrombosis Center, Inc.Aktiv, ikke rekrutterendePlasminogen Activator Inhibitor-1 mangel | HjertefibroseForenede Stater
-
Chinese PLA General HospitalIkke rekrutterer endnuPD-1-hæmmer svigtede patienter med klassisk Hodgkin-lymfom
-
Guangxi Medical UniversityWuzhou Red Cross Hospital; Wuhan Union Hospital, China; Yunnan Cancer Hospital og andre samarbejdspartnereIkke rekrutterer endnuNasopharyngealt karcinom | Neoadjuverende terapi | PD-1 inhibitor
-
Shandong New Time Pharmaceutical Co., LTDIkke rekrutterer endnu
-
Icahn School of Medicine at Mount SinaiRekrutteringKræft | Skjoldbruskkirtel | PD-1Forenede Stater
-
Second Affiliated Hospital, School of Medicine,...RekrutteringHalspulsåreplak | Pd-1 hæmmereKina
-
Wuhan Union Hospital, ChinaRekrutteringGastroøsofageal Junction Cancer | PD-1 | Neoadjuverende kemoradioterapiKina
-
Xijing HospitalRekrutteringPD-1 | Lokalt avanceret gastrisk adenocarcinomKina
-
Xiaorong DongUkendt
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)RekrutteringRefraktær MSI - H faste tumorer forud for PD-(L) 1-terapi | MSI-H tumorerForenede Stater
-
Peking University Third HospitalAfsluttetKræft i bugspytkirtlen | Stereotaktisk kropsstrålebehandling | PD-1 hæmmereKina
-
Beijing Friendship HospitalIkke rekrutterer endnu
-
Fuzhou General HospitalUkendtSmåcellet lungekræft | Lunge-neoplasma | PD-1 hæmmereKina
-
Fudan UniversityIkke rekrutterer endnuEffekten og sikkerheden af PD-1-hæmmere med eller uden strålebehandling hos patienter med avanceret melanomKina
-
Ascletis Pharmaceuticals Co., Ltd.RekrutteringHIV-infektioner | HIV-1-infektion | PD-L1 genmutationKina
-
Samsung Medical CenterUkendt
-
Sichuan Cancer Hospital and Research InstituteIkke rekrutterer endnuIntrahepatisk cholangiocarcinom | Apatinib | PD-1 antistof | Transarteriel kemoemboliseringKina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRekruttering
-
Shanghai Zhongshan HospitalAktiv, ikke rekrutterendeGaldevejskræft | PD-1 antistof | Lenvatinib | GemoxKina
-
Beijing Friendship HospitalAfsluttetGaldevejskræft | Capecitabin | Målrettet molekylær terapi | Anti-PD-1 terapiKina
-
Nanjing Medical UniversityAfsluttetImmun Checkpoint Inhibitor | Endokrin toksicitetKina
-
China Medical University, ChinaIkke rekrutterer endnuPD-1 antistof | Gastrointestinale tumorer | DC-celle | NK-celle
-
Lei LiRekrutteringKemoterapi | Tilbagevendende cervikal karcinom | Immune Checkpoint-hæmmere | Anti-PD-1 antistof | Vedvarende avanceret cervikal karcinom | Albumin-bundet PaclitaxelKina
-
Jiangsu vcare pharmaceutical technology co., LTDAfsluttet
-
Sun Yat-sen UniversityRekrutteringSolid tumor | Tarmflora | Immun Checkpoint InhibitorKina
-
Wuxi People's HospitalRekruttering
-
University Hospital HeidelbergDepartment of Dermatology, Heidelberg University HospitalAfsluttetMelanom | Dyrke motion | PD-1 antistofferTyskland